Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Access Control
LeftNav
Alarms
LeftNav
Biometrics
LeftNav
Detection
LeftNav
Deutsche Zone (German Zone)
LeftNav
Education, Training and Professional Services
LeftNav
Government Programmes
LeftNav
Guarding, Equipment and Enforcement
LeftNav
Industrial Computing Security
LeftNav
IT Security
LeftNav
Physical Security
LeftNav
Surveillance
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
 
News

Implant Sciences replaces President and CEO

Implant Sciences : 08 January, 2009  (Company News)
Senior appointment at detection specialist after board restructuring
Implant Sciences has announced the appointment of Glenn Bolduc as the Company's new President and Chief Executive Officer. In addition, the Board of Directors has appointed Mr Bolduc as a member of the Board. Both appointments were effective January 1, 2009. Prior to these appointments, Mr Bolduc held the position of Chief Financial Officer. Phillip Thomas resigned his positions as the Company's President, Chief Executive Officer and Chairman effective December 31, 2008 to pursue other personal interests.

Phillip Thomas stated, "Almost two years ago I joined Implant Sciences and was charged with the task of leading the Company through a major restructuring enabling the Company to be more competitive in the Security, Safety and Defense (SS&D) industry. During my tenure, we disposed of non-strategic assets; built an industry-focused team capable of meeting the challenges within the SS&D marketplace; made significant sales progress, especially in penetrating the international marketplace; and strengthened our overall financial position during difficult economic times. I believe the Company's restructuring goals have been accomplished, as have my own personal goals. The time is right to hand the reins of the Company over to Glenn Bolduc, who I am certain, will continue executing on the Company's strategic plan."

Glenn Bolduc, President and Chief Executive Officer of Implant Sciences, commented, "We are most appreciative of Phil Thomas' leadership and his efforts to position the Company to be a pure-play in the SS&D industry. With the repositioning task behind us, we are keenly focused on executing our growth plan. We believe our organization has now been properly streamlined so as to be able to take advantage of growth opportunities while doing so in a cost-effective manner. While drawing upon my past experiences in leading companies facing challenges similar to those faced by Implant Sciences today, I look forward to working with our experienced and knowledgeable team in executing our strategic plan. We believe our talented staff and innovative technology form the foundation upon which Implant Sciences can grow into a market leader in the SS&D industry."
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProSecurityZone.com
Netgains Logo